Calymin Tablet 50 Units (Calidogenase)

Adult dose

Administer 30∼150I.U. orally per day in 3 divided doses. Adjust the dose appropriately according to age and symptoms.

This drug should not be used in patients with bleeding, especially in those immediately after a cerebral hemorrhage. This drug contains lactose, so patients with genetic disorders that prevent lactose digestion should avoid taking it. Skin rashes or itching may occur during use, so if these symptoms develop, immediate discontinuation is necessary. Rapid heartbeat may also rarely occur, which should be noted. Gastrointestinal symptoms such as discomfort, nausea, vomiting, loss of appetite, abdominal pain, diarrhea, or constipation may arise. Additionally, fever, headache, a feeling of heaviness in the head, drowsiness, or fatigue may occur, so the patient's condition should be closely monitored. Elderly individuals may have weakened bodily functions, so special caution, such as dosage reduction, is advised when using this drug.

• rash
• itching
• palpitations
• upper abdominal discomfort
• nausea
• vomiting
• loss of appetite
• epigastric pain
• diarrhea
• constipation

This medication should be stored in an airtight container that allows for good air circulation, at room temperature between 1 and 30 degrees. Proper storage maintains the medication's effectiveness and prevents deterioration.

Appearance

White circular enteric-coated tablets

Package unit

300 tablets/bottle, 30 tablets/bottle